Fytexia is formerly owned by ARCHIMED, through MED I, since 2016.

When did ARCHIMED acquire Fytexia?

ARCHIMED acquired Fytexia in 2016 and exited after 7 years.

Has Fytexia been sold?

Yes. Fytexia was exited in 2023 via Trade Sale.

Home/Companies/HealthTech/Fytexia

Fytexia

HealthTech·

France·Exited 2023·Held 7yr

Fytexia is a consumer health company, headquartered in France.

Entry

2016

Hold

7yr

Exit

2023

Est. EV

–

Investor

ARCHIMED

Key facts

HQFrance

SectorConsumer Health

Founded in 2003 in France, Fytexia is a life science company focused on scientifically supported micronutrients for healthcare products. In…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from MED I

Other portfolio companies in the same fund.

Esperion Therapeutics

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

Crédit Mutuel EquityFrance

Last updated April 2026 · Sourced from public filings